Related Experiment Video
Updated: Aug 10, 2026

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
Fecal excretion of hepatitis A virus in humans
Insights
Hepatitis A virus (HAV) shedding in stool is detectable early in illness, before liver enzyme changes. Viral excretion declines before peak liver enzyme levels, suggesting limited transmission risk from symptomatic patients.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Hepatitis A virus (HAV) infection is a significant public health concern.
- Understanding the viral shedding period is crucial for infection control.
- Previous studies on HAV communicability have yielded varied conclusions.
Purpose of the Study:
- To precisely define the duration of fecal virus excretion in children with symptomatic hepatitis A.
- To correlate viral shedding with specific clinical and biochemical markers of hepatitis A.
Main Methods:
- Analysis of 24 fecal samples from six children experiencing clinical hepatitis A during an epidemic.
- Utilized immune electron microscopy (IEM) to detect and quantify viral presence.
- Monitored serum glutamic-pyruvic transaminase (alanine aminotransferase) levels as a marker of liver injury.
Main Results:
- Detectable HAV in fecal samples occurred before or concurrent with the initial rise in serum alanine aminotransferase.
- Viral excretion peaked early in the disease course.
- Fecal virus levels became undetectable before serum enzyme levels reached their peak.
Conclusions:
- Symptomatic individuals with hepatitis A are unlikely to be significant transmitters of the virus.
- Immune electron microscopy is a valuable tool for identifying the period of HAV communicability.
- Standard fecal precautions may not be routinely necessary for hospitalized hepatitis A patients.
Abstract:
To define more completely the period of fecal excretion of virus during hepatitis A virus infection, we studied 24 fecal samples from six children with clinical illness during an epidemic of type A hepatitis. As determined by immune electron microscopy, the six patients had detectable viral excretion before or by the time of the first abnormality in serum glutamic-pyruvic transaminase (alanine aminotransferase). Viral excretion reached a peak early and declined to undetectable levels before levels of serum enzyme reached a peak. These data accord with epidemiologic evidence that the person who already has symptoms and signs of type A hepatitis is unlikely to transmit the infection to others. Immune electron microscopy, therefore, may be a better index to the period of communicability than studies of experimental infection in human subjects. This conclusion would imply that precautions against fecal contamination are not usually necessary for patients hospitalized with type A hepatitis.
Related Concept Videos
Poliomyelitis
Yellow Fever
Hepatitis
Amebiasis
Viral Hepatitis I: Introduction

